BioengineeringbioRxivPreprint
Anti-CD38-Targeted Piperazine-Derived Lipid Nanoparticles Overcome Hepatic Clearance for mRNA Delivery to Multiple Myeloma Cells In Vivo
Christian G. Figueroa‐Espada, Hannah C. Geisler, Ryann A. Joseph…·Michael J. Mitchell
This study develops anti-CD38 lipid nanoparticles for targeted mRNA delivery to multiple myeloma cells, improving tumor targeting and reducing hepatic accumulation.